annual shareholders equity:
$224.53M+$27.55M(+13.98%)Summary
- As of today (July 1, 2025), TARS annual stockholders equity is $224.53 million, with the most recent change of +$27.55 million (+13.98%) on December 31, 2024.
- During the last 3 years, TARS annual shareholders equity has risen by +$57.80 million (+34.67%).
- TARS annual shareholders equity is now at all-time high.
Performance
TARS Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$342.46M+$117.92M(+52.52%)Summary
- As of today (July 1, 2025), TARS quarterly stockholders equity is $342.46 million, with the most recent change of +$117.92 million (+52.52%) on March 31, 2025.
- Over the past year, TARS quarterly shareholders equity has increased by +$67.25 million (+24.43%).
- TARS quarterly shareholders equity is now at all-time high.
Performance
TARS quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
TARS Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.0% | +24.4% |
| 3 y3 years | +34.7% | +129.5% |
| 5 y5 years | +3839.1% | - |
TARS Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +34.7% | at high | +131.8% |
| 5 y | 5-year | at high | +3839.1% | at high | +2020.8% |
| alltime | all time | at high | +3839.1% | at high | +2020.8% |
TARS Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $342.46M(+52.5%) |
| Dec 2024 | $224.53M(+14.0%) | $224.53M(-5.5%) |
| Sep 2024 | - | $237.48M(-5.9%) |
| Jun 2024 | - | $252.25M(-8.3%) |
| Mar 2024 | - | $275.21M(+39.7%) |
| Dec 2023 | $196.99M(+2.1%) | $196.99M(-7.8%) |
| Sep 2023 | - | $213.66M(+44.6%) |
| Jun 2023 | - | $147.73M(-14.8%) |
| Mar 2023 | - | $173.40M(-10.1%) |
| Dec 2022 | $192.90M | $192.90M(-4.8%) |
| Sep 2022 | - | $202.63M(-8.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $221.50M(+48.5%) |
| Mar 2022 | - | $149.20M(-10.5%) |
| Dec 2021 | $166.73M(+0.5%) | $166.73M(-6.9%) |
| Sep 2021 | - | $179.14M(-6.9%) |
| Jun 2021 | - | $192.47M(+5.0%) |
| Mar 2021 | - | $183.23M(+10.4%) |
| Dec 2020 | $165.98M(-2864.0%) | $165.98M(-1031.0%) |
| Sep 2020 | - | -$17.83M(-134.0%) |
| Jun 2020 | - | $52.37M(-972.1%) |
| Dec 2019 | -$6.00M(+343.5%) | -$6.00M |
| Dec 2018 | -$1.35M | - |
FAQ
- What is Tarsus Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual shareholders equity year-on-year change?
- What is Tarsus Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Tarsus Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of TARS is $224.53M
What is the all time high annual shareholders equity for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual stockholders equity is $224.53M
What is Tarsus Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, TARS annual stockholders equity has changed by +$27.55M (+13.98%)
What is Tarsus Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of TARS is $342.46M
What is the all time high quarterly shareholders equity for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly stockholders equity is $342.46M
What is Tarsus Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, TARS quarterly stockholders equity has changed by +$67.25M (+24.43%)